Nevertheless, it is concerning that PTX has been associated with the elevation of glutamic–pyruvic transaminase (ALT) and glutamic–oxalacetic transaminase (AST) ranging from 7% to 26% in cancer patients [87]. The gene discussed is GPT; the disease is cancer.